Therapy Areas Anti-Infectives Cardiovascular & Metabolic CNS / Neuropsychiatry Ophthalmics Gastroenterology & Hepatology Haematology, Nutrition & Supportive Care Hormonal, Nephrology & Specialty Corticosteroids Pain, Analgesics & Musculoskeletal Topical / Dermatology All therapy areas → Markets Capabilities Contact Grow
← All therapy areas

Respiratory

Asthma affected 363 million people in 2023 and killed 442,000. Most of those deaths were in low- and lower-middle-income countries. Steroid inhalers reached under half of their primary health care facilities that year, and bronchodilators under two-thirds.

171 Molecules in range

Five corticosteroids paired with formoterol. One inhaler combines it with tiotropium and ciclesonide.

Range depth

ICS and LABA inhalers

23 formoterol combinations.

  • Formoterol 6mcg & Budesonide 100 / 200 / 400mcg Inhaler
  • Fluticasone 50 / 125 / 250 / 500mcg & Formoterol 6mcg Inhaler
  • Salmeterol 25mcg & Fluticasone 50 / 125 / 250mcg Inhaler
  • Ciclesonide 80 / 160 / 200 / 400mcg & Formoterol 4.5mcg Inhaler
  • Mometasone 100 / 200 / 400mcg & Formoterol 6mcg Inhaler

LAMA and triple therapy

6 tiotropium presentations.

  • Tiotropium 9 / 18mcg Inhaler
  • Tiotropium 9mcg & Formoterol 6 / 12mcg Inhaler
  • Tiotropium 9mcg & Formoterol 6mcg & Ciclesonide 200mcg Inhaler
  • Ipratropium 20 / 40mcg Inhaler
  • Levosalbutamol 50mcg & Ipratropium 20mcg Inhaler

Nasal sprays

  • Mometasone 50mcg Aqueous Nasal Spray
  • Fluticasone Furoate 27.5mcg Nasal Spray
  • Azelastine 140mcg & Fluticasone Propionate 50mcg Nasal Spray
  • Budesonide 50 / 64 / 100mcg Aqueous Nasal Spray

Oral respiratory

24 montelukast presentations.

  • Montelukast 10mg
  • Montelukast 4mg & Levocetirizine 2.5mg per 5ml Syrup
  • Bilastine 20mg & Montelukast 10mg
  • Acebrophylline & Terbutaline & Guaifenesin Syrup
Dosage forms
47Tablet
47Inhaler / MDI
40Liquid / Syrup
30Nasal Spray
6Injectable
1Capsule

Inhaled, nasal and oral.

Tell us the market and what you already stock.

Start the conversation